Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

Ultrasound Obstet Gynecol. 2020 May;55(5):695-696. doi: 10.1002/uog.22030.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cell-Free Nucleic Acids*
  • Female
  • Humans
  • Pregnancy
  • Prenatal Diagnosis

Substances

  • Cell-Free Nucleic Acids